Medidata and Sanofi collaborate for remote patient monitoring with real-time data

Medidata, a clinical trial solutions provider, has joined forces with Sanofi Vaccines to leverage Medidata's Electronic Clinical Outcomes Assessment (eCOA) for the creation of an electronic diary database dedicated to Sanofi vaccines. This collaboration seeks to streamline deployment time for upcoming studies, enhance efficiency, and ensure the development of patient-friendly electronic diaries with high data quality. 

Sanofi has a decade-long partnership with Medidata, and this extension of collaboration involves expanding the use of Medidata eCOA in vaccine research, particularly in conjunction with Medidata Rave EDC (electronic data capture). The joint efforts aim to improve the overall patient experience, accelerate research timelines, and optimise efficiency in vaccine clinical trials.

Sanofi plans to implement eCOA in its vaccine studies to enhance the clinical experience for patients, allowing real-time data entry from any location and reducing the need for on-site monitoring. Recent pilot studies incorporating eCOA have demonstrated positive outcomes, including good patient compliance and reliable data. The success of these trials has prompted the formal expansion of cooperation between Medidata and Sanofi, with eCOA now being widely utilised in various vaccine clinical trials. As part of the unified Medidata Platform, eCOA not only significantly reduces research database construction time but also offers a comprehensive view of patient data, granting participants flexibility and choice in engaging with clinical trial activities.